We are live on ! Find out more
GC

Guggenheim Capital Portfolio holdings

AUM $12.9B
1-Year Est. Return 27.3%
This Fund
S&P 500
This Quarter Est. Return
-0.8%
1 Year Est. Return
+27.3%
3 Year Est. Return
+83.37%
5 Year Est. Return
+104.66%
10 Year Est. Return
+359.15%
AUM
$40.5B
AUM Growth
-$1.74B
Cap. Flow
-$1.03B
Cap. Flow %
-2.55%
Top 10 Hldgs %
7.42%
Holding
3,192
New
162
Increased
1,347
Reduced
1,471
Closed
153

Sector Composition

Rank Sector Weight
1 Healthcare 13.53%
2 Technology 11.68%
3 Financials 10.76%
4 Consumer Discretionary 10.34%
5 Industrials 8.71%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
DRRX
2926
DELISTED
DURECT Corp
DRRX
$73K ﹤0.01%
3,034
+1,327
+78% +$31.2K
EXXI
2927
DELISTED
ENERGY XXI LTD COM SHS
EXXI
$73K ﹤0.01%
27,749
+3,557
+15% +$13.1K
CWST icon
2928
Casella Waste Systems
CWST
$5.73B
$71K ﹤0.01%
12,607
-627
-5% -$3.51K
HLIT icon
2929
Harmonic Inc
HLIT
$1.3B
$70K ﹤0.01%
10,188
+144
+1% +$1.02K
NEO icon
2930
NeoGenomics
NEO
$2.02B
$69K ﹤0.01%
+12,894
New +$66.5K
ZGNX
2931
DELISTED
Zogenix, Inc.
ZGNX
$69K ﹤0.01%
5,093
-23
-0.4% -$282
NBG
2932
DELISTED
NATIONAL BANK OF GREECE SA ADR REPSTG 1 SHARE (NEW)
NBG
$69K ﹤0.01%
65,400
+23,785
+57% +$30.7K
RDNT icon
2933
RadNet
RDNT
$5.27B
$68K ﹤0.01%
+10,094
New +$77.4K
DXLG icon
2934
Destination XL Group
DXLG
$30.7M
$67K ﹤0.01%
13,257
+1,030
+8% +$5.12K
CDMO
2935
DELISTED
Avid Bioservices, Inc. Common Stock
CDMO
$66K ﹤0.01%
7,125
+319
+5% +$3.07K
DALN
2936
DELISTED
DallasNews
DALN
$65K ﹤0.01%
2,888
-586
-17% -$15.4K
LCTX icon
2937
Lineage Cell Therapeutics
LCTX
$284M
$65K ﹤0.01%
22,396
-283
-1% -$1.1K
OCLR
2938
DELISTED
Oclaro Inc.
OCLR
$65K ﹤0.01%
28,626
+582
+2% +$1.3K
SSE
2939
DELISTED
SEVENTY SEVEN ENERGY INC COM
SSE
$65K ﹤0.01%
15,224
-63,895
-81% -$337K
RTK
2940
DELISTED
Rentech, Inc.
RTK
$63K ﹤0.01%
5,913
+1,154
+24% +$13.2K
ARR
2941
Armour Residential REIT
ARR
$2.35B
$62K ﹤0.01%
553
-33,716
-98% -$4.1M
UCFC
2942
DELISTED
United Community Financial Corp
UCFC
$62K ﹤0.01%
11,501
+197
+2% +$1.07K
RXII
2943
DELISTED
GALENA BIOPHARMA INC COM
RXII
$62K ﹤0.01%
36,362
+1,837
+5% +$3.13K
ALR
2944
DELISTED
AlerisLife Inc
ALR
$61K ﹤0.01%
1,269
+46
+4% +$2.09K
PTX
2945
DELISTED
Pernix Therapeutics Holdings, Inc.
PTX
$60K ﹤0.01%
+1,021
New +$72K
GTI
2946
DELISTED
GRAFTECH INTERNATIONAL LTD
GTI
$57K ﹤0.01%
11,457
+51
+0.4% +$241
EXEL icon
2947
Exelixis
EXEL
$14.3B
$55K ﹤0.01%
14,521
-7,492
-34% -$24.4K
TSYS
2948
DELISTED
TELECOMMUNICATIONS SYS INC "A"
TSYS
$55K ﹤0.01%
16,791
+1,173
+8% +$3.95K
GERN icon
2949
Geron
GERN
$1.05B
$53K ﹤0.01%
12,315
-1,316
-10% -$5.22K
CYNI
2950
DELISTED
CYAN INC COM
CYNI
$53K ﹤0.01%
10,161
-2,959
-23% -$14.3K

Similar funds

Guggenheim Capital's Q2 2015 Portfolio in Review

As of Q2 2015, Guggenheim Capital held 3,192 positions worth $40.5B, down 4.1% from $42.2B the previous quarter. Its ten largest holdings account for 7.4% of the portfolio.

Guggenheim Capital's Q2 2015 filing shows 162 new, 1,347 increased, 1,471 reduced and 153 closed positions. Its largest new stake was State Street SPDR Dow Jones Industrial Average ETF Trust: 158,500 shares worth $27.9M. The largest sale was Covanta Holding Corporation, an estimated $71.6M.

By sector, the portfolio is most concentrated in Healthcare at 14% of assets, up from 12% a quarter earlier, followed by Technology and Financials.

  • Guggenheim Capital's largest Q2 2015 buy was State Street SPDR Dow Jones Industrial Average ETF Trust: 158,500 shares worth $27.9M.
  • Guggenheim Capital added most to Qorvo in Q2 2015, an estimated $45.3M increase.
  • Guggenheim Capital's biggest Q2 2015 reduction was Covanta Holding Corporation, cutting an estimated $71.6M.
  • Guggenheim Capital fully exited LORILLARD INC COM STK in Q2 2015, selling an estimated $66M.
  • Guggenheim Capital's ten largest holdings make up 7.4% of its $40.5B portfolio in Q2 2015.
  • Guggenheim Capital opened 162 new positions and closed 153 in Q2 2015.
  • Guggenheim Capital's portfolio value fell 4.1% quarter-over-quarter to $40.5B.

Based on Guggenheim Capital's 13F filing for Q2 2015, filed 14 Aug 2015.